Short‐Term Oral Administration of the Porcupine Inhibitor, Wnt‐c59, Improves the Structural and Functional Features of Experimental HFpEF

Documenti analoghi

• Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108, a Novel Potent Tropomyosin Receptor Kinase Inhibitor
  di: Xiaochen Zhang, et al.
  Pubblicazione: (2025)
• Sex‐Dependent Long‐Term Neurobehavioral Recovery in Experimental Neonatal Hypoxic–Ischemic Encephalopathy
  di: Elisa Landucci, et al.
  Pubblicazione: (2025)
• Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β‐Catenin Signaling Pathway in MCF‐7 Cells
  di: Şeyda Nur Kalın, et al.
  Pubblicazione: (2025)
• The Absorption, Distribution, Metabolism, and Excretion of Binimetinib Following a Single Oral Dose of [14C]Binimetinib 45 mg in Healthy Male Participants
  di: Dustin Huynh, et al.
  Pubblicazione: (2025)
• Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective
  di: Mariam Rizk, et al.
  Pubblicazione: (2025)